Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51


A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer.

Wu J, Huang Q, Meng D, Huang M, Li C, Qin T.

PLoS One. 2016 Jul 20;11(7):e0159115. doi: 10.1371/journal.pone.0159115.


Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses.

Al-Zalabani AH, Stewart KF, Wesselius A, Schols AM, Zeegers MP.

Eur J Epidemiol. 2016 Sep;31(9):811-51. doi: 10.1007/s10654-016-0138-6. Review.


Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada.

Saint-Jacques N, Lee JS, Brown P, Stafford J, Parker L, Dummer TJ.

BMC Public Health. 2016 Feb 19;16:175. doi: 10.1186/s12889-016-2767-9.


Correlation between XRCC1 Arg399Gln genetic polymorphisms and susceptibility to bladder cancer: a meta-analysis.

Liu N, Fei X, Shen Y, Shi W, Ma J.

Onco Targets Ther. 2016 Jan 28;9:579-86. doi: 10.2147/OTT.S95658.


Arsenic in Drinking Water, Transition Cell Cancer and Chronic Cystitis in Rural Bangladesh.

Mostafa MG, Cherry N.

Int J Environ Res Public Health. 2015 Oct 28;12(11):13739-49. doi: 10.3390/ijerph121113739.


Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformation.

Lee HW, Wang HT, Weng MW, Chin C, Huang W, Lepor H, Wu XR, Rom WN, Chen LC, Tang MS.

Oncotarget. 2015 Oct 20;6(32):33226-36. doi: 10.18632/oncotarget.5429.


Smoking-induced immune deviation contributes to progression of bladder and other cancers.

M Clement J, Duan F, Srivastava PK.

Oncoimmunology. 2015 May 27;4(9):e1019199.


Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer.

McBeth L, Grabnar M, Selman S, Hinds TD Jr.

Int J Endocrinol. 2015;2015:384860. doi: 10.1155/2015/384860. Review.


Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

Lin YC, Wu X, Zhou XQ, Ren R, Su ZX, Liu CX.

Int J Clin Exp Med. 2015 Jun 15;8(6):8927-37.


Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.

Ai X, Jia ZM, Wang J, DI GP, Zhang XU, Sun F, Zang T, Liao X.

Oncol Lett. 2015 Jul;10(1):543-549.


Functional POR A503V is associated with the risk of bladder cancer in a Chinese population.

Xiao X, Ma G, Li S, Wang M, Liu N, Ma L, Zhang Z, Chu H, Zhang Z, Wang SL.

Sci Rep. 2015 Jun 30;5:11751. doi: 10.1038/srep11751.


Diabetes mellitus and the risk of bladder cancer: an Italian case–control study.

Turati F, Polesel J, Di Maso M, Montella M, Libra M, Grimaldi M, Tavani A, Serraino D, La Vecchia C, Bosetti C.

Br J Cancer. 2015 Jun 30;113(1):127-30.


Targeting Hsp90 in urothelial carcinoma.

Chehab M, Caza T, Skotnicki K, Landas S, Bratslavsky G, Mollapour M, Bourboulia D.

Oncotarget. 2015 Apr 20;6(11):8454-73. Review.


Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997-2008.

Wang SM, Lai MN, Chen PC, Pu YS, Lai MK, Hwang JS, Wang JD.

Biomed Res Int. 2014;2014:149750. doi: 10.1155/2014/149750.


Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.

Shin K, Lim A, Odegaard JI, Honeycutt JD, Kawano S, Hsieh MH, Beachy PA.

Nat Cell Biol. 2014 May;16(5):469-78. doi: 10.1038/ncb2956. Erratum in: Nat Cell Biol. 2014 Jun;16(6):620.


Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.

King SC, Pollack LA, Li J, King JB, Master VA.

J Urol. 2014 Jun;191(6):1665-70. doi: 10.1016/j.juro.2013.12.046.


Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.

Wang SS, Liu YF, Ou YC, Chen CS, Li JR, Yang SF.

PLoS One. 2013 Dec 13;8(12):e82804. doi: 10.1371/journal.pone.0082804.


Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment.

Parker BC, Zhang W.

Chin J Cancer. 2013 Nov;32(11):594-603. doi: 10.5732/cjc.013.10178.


Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer.

Hung SY, Yang WC, Luo HL, Hsu CC, Chen YT, Chuang YC.

Int Urol Nephrol. 2014 May;46(5):921-6. doi: 10.1007/s11255-013-0514-z.


Differences in the cancer burden among foreign-born and US-born Arab Americans living in metropolitan Detroit.

Khan F, Ruterbusch JJ, Gomez SL, Schwartz K.

Cancer Causes Control. 2013 Nov;24(11):1955-61. doi: 10.1007/s10552-013-0271-4.

Items per page

Supplemental Content

Support Center